|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1038
|
$965B |
15.1x |
33.4x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$241
|
$608B |
6.5x |
17.0x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$228
|
$465B |
7.6x |
17.8x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 361
|
$398B |
4.9x |
12.5x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£148
|
$338B |
5.7x |
16.3x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 124
|
$332B |
5.8x |
14.1x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$119
|
$319B |
4.9x |
10.7x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$366
|
$243B |
6.7x |
13.8x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 307
|
$234B |
4.8x |
9.8x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$152
|
$206B |
7.1x |
12.9x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$202B |
3.3x |
8.2x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$60
|
$157B |
3.3x |
8.4x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£22
|
$138B |
3.1x |
9.2x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€83
|
$134B |
2.5x |
8.3x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$465
|
$113B |
9.4x |
21.0x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€46
|
$92.8B |
1.7x |
8.2x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 9200
|
$90.7B |
11.4x |
22.3x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5609
|
$82.9B |
2.9x |
10.6x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€125
|
$75.8B |
3.0x |
10.5x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 152
|
$62.3B |
3.7x |
10.9x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$129
|
$61.9B |
6.6x |
15.0x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 104
|
$52.8B |
3.0x |
10.0x |
|
Jiangsu Hengrui Pharma
|
Hong Kong |
Biopharmaceuticals
|
HKD 67
|
$50.7B |
10.9x |
36.4x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 59
|
$50.6B |
10.6x |
35.1x |
|
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 498
|
$50.0B |
5.1x |
17.3x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1715
|
$42.7B |
6.9x |
24.2x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 66
|
$41.2B |
3.6x |
16.7x |
|
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 238500
|
$37.1B |
13.1x |
36.5x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2906
|
$32.0B |
2.4x |
12.0x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$16
|
$31.8B |
2.3x |
7.7x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 9871
|
$31.5B |
2.0x |
8.4x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$196
|
$31.5B |
3.2x |
10.3x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2470
|
$31.2B |
2.4x |
10.2x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$44
|
$26.0B |
8.8x |
9.0x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 37
|
$24.4B |
11.6x |
30.2x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 8
|
$21.9B |
2.1x |
6.0x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 89
|
$18.7B |
9.7x |
107.5x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$17.7B |
2.0x |
8.1x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 408
|
$17.0B |
5.3x |
13.8x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 289
|
$16.9B |
52.9x |
N/A |
|
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 3535
|
$15.6B |
5.0x |
12.5x |
|
Torrent Pharmaceuticals
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 4077
|
$15.4B |
11.1x |
33.6x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1881
|
$15.2B |
4.1x |
10.7x |
|
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 390000
|
$14.0B |
91.2x |
169.8x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€47
|
$13.9B |
4.5x |
12.0x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$13.9B |
2.9x |
10.8x |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 10
|
$13.5B |
3.4x |
13.6x |
|
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 30
|
$13.2B |
3.9x |
9.3x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 25
|
$13.0B |
2.2x |
13.6x |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€139
|
$12.9B |
2.9x |
7.6x |
|
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.8B |
2.1x |
14.3x |
|
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€229
|
$12.1B |
N/A |
N/A |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 423
|
$12.0B |
43.0x |
-260.2x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 104
|
$11.9B |
25.1x |
-1183.0x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.9B |
0.3x |
5.0x |
|
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1275
|
$11.5B |
3.1x |
12.6x |
|
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€67
|
$11.4B |
5.1x |
13.6x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$123
|
$11.3B |
4.0x |
17.1x |
|
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2210
|
$11.1B |
4.0x |
15.6x |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1330
|
$10.7B |
3.4x |
14.0x |
|
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 921
|
$10.4B |
3.8x |
13.6x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$10.0B |
1.6x |
5.2x |
|
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2079
|
$10.0B |
6.5x |
25.9x |
|
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 65
|
$9.9B |
11.6x |
37.7x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$77
|
$9.9B |
7.4x |
11.2x |
|
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 36
|
$8.9B |
1.4x |
11.1x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$324
|
$8.7B |
29144.4x |
-29.3x |
|
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€98
|
$8.6B |
832.2x |
-35.3x |
|
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4960
|
$8.4B |
1.6x |
13.3x |
|
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€237
|
$7.9B |
3.3x |
9.9x |
|
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 375
|
$7.8B |
4.2x |
20.2x |
|
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 104
|
$7.6B |
18.7x |
-3113.7x |
|
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5871
|
$7.4B |
4.8x |
23.8x |
|
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 38
|
$7.3B |
N/A |
N/A |
|
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1158
|
$7.3B |
2.0x |
9.7x |
|
Kyowa Kirin Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2570
|
$7.2B |
2.3x |
10.3x |
|
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2505
|
$7.1B |
2.2x |
9.4x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$15
|
$7.1B |
2.4x |
10.4x |
|
ABL Bio
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 189200
|
$7.1B |
90.9x |
15916.9x |
|
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 725
|
$7.0B |
14.5x |
43.7x |
|
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 29
|
$6.5B |
1.5x |
8.6x |
|
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 23
|
$6.5B |
2.4x |
3.5x |
|
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 11760
|
$6.4B |
2.2x |
6.0x |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$175
|
$6.3B |
N/A |
N/A |
|
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 6
|
$6.2B |
N/A |
N/A |
|
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2034
|
$6.1B |
3.5x |
23.3x |
|
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 64
|
$6.1B |
6.8x |
23.9x |
|
Hebei Changshan
|
China |
Biopharmaceuticals
|
CNY 43
|
$6.1B |
N/A |
N/A |
|
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£16
|
$6.0B |
1.8x |
7.0x |
|
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 26685
|
$6.0B |
8.0x |
29.3x |
|
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 339
|
$6.0B |
N/A |
N/A |
|
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 147
|
$6.0B |
16.4x |
24.4x |
|
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 109176
|
$5.6B |
3.6x |
41.3x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$5.5B |
N/A |
-20.4x |
|
Hanmi Pharm
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 614000
|
$5.5B |
5.3x |
24.2x |
|
Henlius Biotech
|
Hong Kong |
Biopharmaceuticals
|
HKD 72
|
$5.4B |
6.4x |
32.5x |
|
Gan and Lee
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 66
|
$5.2B |
8.6x |
25.8x |
|
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 109
|
$4.9B |
1.8x |
10.4x |
|
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 88
|
$4.8B |
2.4x |
9.1x |
|
Laboratorios Rovi
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€77
|
$4.8B |
5.6x |
20.7x |